- Severe aplastic anemia induced by ticlopidine: report of two cases
-
Bahng H, Lee JH, Suh C, Ahn JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS, Kim SH
- KMID: 645216
- J Korean Med Sci.
- 1998 Oct;13(5):541-544.
- doi: 10.3346/jkms.1998.13.5.541
Aplastic anemia is a rare side-effect associated with ticlopidine therapy. We report two cases of severe aplastic anemia developed after the use of ticlopidine. A 51-year-old woman took ticlopidine... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation
-
Ahn JH, Lee JH, Lee KH, Kim WK, Lee JS, Bahng H, Jung HY, Kim YS, Kim O, Kim SH
- KMID: 759091
- Korean J Intern Med.
- 1999 Jan;14(1):91-94.
Cytomegalovirus(CMV) disease is a major cause of morbidity and mortality in immunocompromised patients. CMV enteritis should be considered when nausea and vomiting continue 3 to 4 weeks after... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Implications of Cytarabine Dose in Consolidation Chemotherapy for the Patients with Acute Myelogenous Leukemia
-
Lee JH, Lee JH, Lee KH, Bahng H, Ahn JH, Lee JS, Kim SH, Kim WK
- KMID: 1815313
- J Korean Cancer Assoc.
- 2000 Oct;32(5):954-961.
PURPOSE: Increasing the dose of cytarabine in consolidation chemotherapy has been suggested to improve treatment outcome of the patients with acute myelogenous leukemia (AML) in complete remission (CR). We studied... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytarabine Plus Daunorubicin or Idarubicin as Induction Chemotherapy for the Patients with De novo Acute Myelogenous Leukemia
-
Ahn JH, Lee JH, Lee KH, Bahng H, Lee JH, Lee JS, Kim SH, Kim WK
- KMID: 2143343
- Korean J Hematol.
- 2000 Nov;35(3-4):214-221.
BACKGROUND: The combination of cytarabine plus anthracycline has been considered standard chemotherapy for acute myelogenous leukemia (AML). We retrospectively analyzed the treatment results of the patients with de novo AML... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Analysis of the Results of Adjuvant Chemotherapy in Breast Cancer Patients with 10 or More Positive Nodes: Nonrandomized Comparison of Adriamycin-Containing Regimens
-
Ahn JH, Bahng H, Kim JG, Kim SB, Ahn SH, Chang H, Lee JS, Kim SH, Kim WK
- KMID: 1972948
- Cancer Res Treat.
- 2002 Apr;34(2):84-90.
PURPOSE: To evaluate the results of adriamycin-based adjuvant chemotherapy with or without high dose chemotherapy (HDC) with stem cell transplantation (SCT) in breast cancer with 10 or more positive axillary... -
- CITED
-
- Close
- SHARE
-
- Close
